Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Therapeutic Indication Insights Primary weight management is anticipated to command nearly 54% of the obesity GLP-1 market share in 2026
This framing matters
Other highlights from the report include: Increased utilization (+7.9%) and new drug introductions (+2.5%) were the primary drivers of higher spending in 2024, while drug prices remained essentially flat (-0.2%)
L-Lysine and l-proline contribute to collagen structure and protein synthesis
PlexusDx providers can also recommend dosing protocols that include brief pauses or adjustments to prevent your body from fully adapting
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
